Transfemoral puncture
Conditions
Interventions
Group 1:hemostasis system
Group 2:ExoSeal hemostasis system
Sponsors
Xuanwu Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years, male or infertile female; 2. Patients who underwent angiography or interventional surgery through femoral artery puncture; 3. Angiography or interventional surgery using 5-7F guided sheath with length less than 12 cm; 4. Subjects or their legal guardians volunteered to participate in the experiment and signed a written consent.
Exclusion criteria
Exclusion criteria: 1. Common femoral artery occlusion or visual lumen diameter less than 5 mm; 2. ST-segment elevation myocardial infarction within 48 hours before intervention; 3. Patients with uncontrollable hypertension during occlusion (blood pressure (> 180/110 mm Hg); 4. Patients with symptomatic ischemia of the limbs and legs of the target vessel, or with femoral artery surgery or vascular transplantation of the target vessel; 5. Preoperative activated partial thromboplastin time (APTT) > upper limit of normal value + 10 seconds; 6. Patients receiving thrombolytic therapy (e.g. streptokinase, urokinase, t-PA) less than 24 hours before closure of blood vessels; 7. Patients who received bivalirudine or low molecular weight heparin within 24 hours before puncture; 8. Patients requiring bilateral femoral artery puncture; 9. Patients with target femoral artery puncture within 30 days before interventional therapy; 10. In patients with visible calcification, atherosclerotic disease or stent implantation, the distance between stent implantation and puncture point is less than 1 cm; 11. Suffer from systemic infection or skin infection; 12. To study the lower extremity arteriosclerosis obliterans and not suitable for femoral artery puncture; 13. Patients with anterograde femoral artery puncture; 14. Women in pregnancy or lactation or men or women with fertility plans in the next six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Instrument success rate; | — |
Countries
China
Contacts
Public ContactLiqun Jiao
Xuanwu Hospital, Capital Medical University
Outcome results
None listed